Browsing Department of Clinical Medicine by Subject "Neurocognitive"
Now showing items 1-1 of 1
Does changing from a first generation antipsychotic (perphenazin) to a second generation antipsychotic (risperidone) alter brain activation and motor activity? A case report (BioMed Central, 2013-05-06)Background: In patients with schizophrenia, altered brain activation and motor activity levels are central features, reflecting cognitive impairments and negative symptoms, respectively. Newer studies using nonlinear ...Journal article